Evidence map›Paper›PMID 35389282›Full record

ArticleJournal of medical screening2022

Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England.

Hannah Drysdale, Laura Av Marlow, Anita Lim, Peter Sasieni, Jo Waller

Abstract read
In one paragraph

Article in Journal of medical screening, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Quality indicators for cervical screening in Sweden.Journal of medical screening · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Urine human papillomavirus testing for cervical screening in a UK general screening population: a diagnostic test accuracy study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Recommendations for a Communication Strategy to Support Informed Decision-Making About Self or Clinician Sampling for Cervical Screening in the UK: Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hannah DrysdaleCancer Prevention Group, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, UK.ORCID 0000-0002-4307-6166
Laura Av MarlowCancer Prevention Group, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, UK.ORCID 0000-0003-1709-2397
Anita LimCancer Prevention Group, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, UK.ORCID 0000-0002-4407-7451
Peter SasieniCancer Prevention Group, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, UK.
Jo WallerCancer Prevention Group, School of Cancer and Pharmaceutical Sciences, 4616King's College London, London, UK.ORCID 0000-0003-4025-9132

Funding

Cancer Research UK 25356Cancer Research UK 27047Cancer Research UK C7492/A17219Cancer Research UK C8162/A27047
6 · The paper itself

Abstract

objectivesThis study assessed preferences for human papillomavirus (HPV) self-sampling if offered as an alternative to clinician-based screening at the point of invitation for cervical screening. SETTING AND

methodsAn online questionnaire was completed by screening-eligible women living in England (n = 3672). Logistic regressions explored associations between demographic characteristics and screening preferences, stratified by previous screening attendance. Reasons for preferences were also assessed.

resultsHalf of participants (51.4%) intended to choose self-sampling, 36.5% preferred clinician screening, 10.5% were unsure, and <2% preferred no screening. More irregular and never attenders chose self-sampling, compared with regular attenders (71.1% and 70.1% vs. 41.0% respectively). Among regular attenders, self-sampling was preferred more frequently by the highest occupational grade, older and lesbian, gay and bisexual women, and those with experience of blood self-tests. In the irregular attender group, older women and those with experience of blood self-tests were more likely to choose self-sampling. In 'never attenders', self-sampling was less popular in ethnic minority groups.

conclusionsIf offered a choice of screening, around half of women in England may choose self-sampling, but a substantial proportion would still opt for clinician screening. Screening providers will need to manage a high take-up of self-sampling if many regular attenders switch to self-sampling.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsAgedCross-Sectional StudiesEarly Detection of CancerEnglandEthnicityFemaleHumansMass ScreeningMinority GroupsPapillomaviridaeSelf CareSpecimen HandlingVaginal Smearsattenderscervical screeninghealthcare disparitieshuman papillomavirusnon-attenderspopulation surveyscreening choiceSelf-samplingsocial class

Identifiers

PMID35389282
PMCPMC9381689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.